South & Central America Transient Protein Expression Market Forecast to 2031 - Regional Analysis - by Product Type, Application, and End User

Description

List of Tables

The South & Central America transient protein expression market was valued at US$ 43.70 million in 2023 and is expected to reach US$ 64.23 million by 2031; it is estimated to register a CAGR of 4.9% from 2023 to 2031.

Increasing Applications of Protein Expression Systems Fuel South & Central America Transient Protein Expression Market

Animal and plant cell-based transient protein expression systems have been in use for the last three decades. Significant advancements in proteomics in recent years have resulted in the availability of newer recombinant protein varieties. The practicality and reproducibility of transient protein expression in animal and plant cells encourage research and development activities to extend their applications in human cell lines. Many contract research and development organizations as well as biopharmaceutical companies, among others, have focused their efforts on incorporating transient protein expression into their production processes. This type of expression system allows them to use different genes to create recombinant proteins without relying on the development of stable cell lines.

The temporary protein expression process finds widespread application in the manufacturing of growth factors, cytokines, hormones, blood products, modified human proteins, and monoclonal antibodies. Moreover, the creation and use of effective bioprocessing techniques have become essential for the commercial synthesis of recombinant proteins with significant therapeutic value. Recent developments in the field of bioprocessing are being applied to provide efficient methods for generating recombinant proteins. Modern Quality by Design concepts, continuous upstream processing, continuous chromatography, integrated continuous bioprocessing, high-throughput devices for efficient bioprocess optimization, disposable systems, and process analytics technologies for higher yields of high-quality products are among the recent developments.

Transient protein expression platforms are increasingly being used in vaccine development applications since the onset of the COVID-19 pandemic. Various researchers began studying the SARS-CoV-2 and its variants extensively by using transient protein expression systems. For instance, in March-April 2020, Absolute Antibody (UK) scaled up the production of multigram quantities of different anti-SARS-CoV-2 spike proteins to aid in the development of neutralizing antibodies. Similarly, transient protein expression systems were widely used to produce positive control proteins as a part of the in-vitro diagnostics kits development processes. Thus, the increasing applications of protein expression systems fuel the transient protein expression market growth.

South & Central America Transient Protein Expression Market Overview

The South & Central America transient protein expression market is segmented into Argentina, Brazil, and the Rest of South & Central America. Brazil is expected to hold the major market share in this region. The transient protein expression market in this region is expected to grow rapidly due to expanding healthcare facilities, rising prevalence of genetic disorders and growing popularity of precision medicine in the region.

South & Central America Transient Protein Expression Market Revenue and Forecast to 2031 (US$ Million)

South & Central America Transient Protein Expression Market Segmentation

The South & Central America transient protein expression market is categorized into product type, application, end user, and country.

Based on product type , the South & Central America transient protein expression market is segmented into instruments, reagents, expression vectors, and competent cells. The instruments segment held the largest market share in 2023.

In terms of application , the South & Central America transient protein expression market is segmented into genomic research, gene therapy, bio production, cancer research, and drug development. The genomic research segment held the largest market share in 2023.

Based on end user , the South & Central America transient protein expression market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and clinical research organizations. The pharmaceutical and biotechnology companies segment held the largest market share in 2023.

By country, the South & Central America transient protein expression market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America transient protein expression market share in 2023.

Thermo Fisher Scientific Inc, Merck KGaA, QIAGEN NV, GenScript Biotech Corporation, Promega Corp, Takara Bio Inc, New England Biolabs, Agilent Technologies Inc, Mirus Bio LLC, Bio-Rad Laboratories Inc, Lonza Group AG, and MaxCyte Inc are some of the leading companies operating in the South & Central America transient protein expression market.

Product Code: TIPRE00022180

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. South & Central America Transient Protein Expression Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Applications of Protein Expression Systems
- 4.1.2 Surging Popularity of Precision Medicine
4.2 Market Restraints
- 4.2.1 High Cost of Products
4.3 Market Opportunities
- 4.3.1 Plant-Based Expression Systems for Therapeutic Protein Production
4.4 Future Trends
- 4.4.1 Integration of Artificial Intelligence (AI) and Automation Technologies
4.5 Impact of Drivers and Restraints:

5. Transient Protein Expression Market - South & Central America Analysis

5.1 South & Central America Transient Protein Expression Market Revenue (US$ Million), 2021-2031
5.2 South & Central America Transient Protein Expression Market Forecast Analysis

6. South & Central America Transient Protein Expression Market Analysis - by Product Type

6.1 Instruments
- 6.1.1 Overview
- 6.1.2 Instruments: South & Central America Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
6.2 Reagents
- 6.2.1 Overview
- 6.2.2 Reagents: South & Central America Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Expression Vectors
- 6.3.1 Overview
- 6.3.2 Expression Vectors: South & Central America Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
6.4 Competent Cells
- 6.4.1 Overview
- 6.4.2 Competent Cells: South & Central America Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)

7. South & Central America Transient Protein Expression Market Analysis - by Application

7.1 Genomic Research
- 7.1.1 Overview
- 7.1.2 Genomic Research: South & Central America Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Gene Therapy
- 7.2.1 Overview
- 7.2.2 Gene Therapy: South & Central America Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Bio production
- 7.3.1 Overview
- 7.3.2 Bio production: South & Central America Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Cancer Research
- 7.4.1 Overview
- 7.4.2 Cancer Research: South & Central America Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Drug Development
- 7.5.1 Overview
- 7.5.2 Drug Development: South & Central America Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)

8. South & Central America Transient Protein Expression Market Analysis - by End User

8.1 Pharmaceutical and Biotechnology Companies
- 8.1.1 Overview
- 8.1.2 Pharmaceutical and Biotechnology Companies: South & Central America Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Academic and Research Institutes
- 8.2.1 Overview
- 8.2.2 Academic and Research Institutes: South & Central America Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Research Organizations
- 8.3.1 Overview
- 8.3.2 Clinical Research Organizations: South & Central America Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)

9. South & Central America Transient Protein Expression Market - Country Analysis

9.1 South & Central America
- 9.1.1 South & Central America Transient Protein Expression Market Overview
- 9.1.2 South & Central America Transient Protein Expression Market - Revenue and Forecast Analysis - by Country
  - 9.1.2.1 South & Central America Transient Protein Expression Market - Revenue and Forecast Analysis - by Country
  - 9.1.2.2 Brazil: South & Central America Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.2.2.1 Brazil: South & Central America Transient Protein Expression Market Breakdown, by Product Type
    - 9.1.2.2.2 Brazil: South & Central America Transient Protein Expression Market Breakdown, by Application
    - 9.1.2.2.3 Brazil: South & Central America Transient Protein Expression Market Breakdown, by End User
  - 9.1.2.3 Argentina: South & Central America Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.2.3.1 Argentina: South & Central America Transient Protein Expression Market Breakdown, by Product Type
    - 9.1.2.3.2 Argentina: South & Central America Transient Protein Expression Market Breakdown, by Application
    - 9.1.2.3.3 Argentina: South & Central America Transient Protein Expression Market Breakdown, by End User
  - 9.1.2.4 Rest of South & Central America Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.2.4.1 Rest of South & Central America Transient Protein Expression Market Breakdown, by Product Type
    - 9.1.2.4.2 Rest of South & Central America Transient Protein Expression Market Breakdown, by Application
    - 9.1.2.4.3 Rest of South & Central America Transient Protein Expression Market Breakdown, by End User

10. Competitive Landscape

10.1 Company Positioning & Concentration

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in South & Central America Transient Protein Expression Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Thermo Fisher Scientific Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Merck KGaA
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 QIAGEN NV
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 GenScript Biotech Corporation
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Promega Corp
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Takara Bio Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 New England Biolabs
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Agilent Technologies Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Mirus Bio LLC
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Bio-Rad Laboratories Inc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Lonza Group AG
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 MaxCyte Inc
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms